Tag
An MIT Technology Review article explores the various uses of cloning, from conservation efforts to pet cloning and potential human applications, noting both its benefits and ethical concerns.
TechCrunch Disrupt 2026 announces a new Real World AI Stage focusing on AI in the physical world, featuring robots, automated factories, and de-extinction, with speakers from Shield AI, Colossal Biosciences, FieldAI, and more, October 13-15 in San Francisco.
Colossal Biosciences is reportedly in talks to raise new capital at a valuation between $20 billion and $30 billion, a significant increase from its previous $10.2 billion valuation. The round is not yet confirmed, and final terms are unknown.
A de-extinction company has successfully hatched live chicks from artificial eggshells, a significant milestone in biotechnology that could advance de-extinction efforts.
Colossal Biosciences successfully hatched 26 chickens using synthetic eggshells, a key step toward de-extinction of birds like the dodo and moa.
Colossal has developed an artificial eggshell that allows chicken embryos to develop normally outside the shell, potentially aiding de-extinction efforts and providing a tool for developmental biology research.
Colossal Biosciences announced a 3D-printed artificial eggshell to grow chicken embryos, aiming to revive extinct birds like the dodo and moa, though experts note prior similar work.